Table of Contents
Hepatitis Research and Treatment
Volume 2014, Article ID 159206, 7 pages
http://dx.doi.org/10.1155/2014/159206
Research Article

Transplacental Transfer of Hepatitis B Neutralizing Antibody during Pregnancy in an Animal Model: Implications for Newborn and Maternal Health

1Laboratory of Plasma Derivatives, Division of Hematology, Office of Blood Research and Review, Center for Biologics Evaluation and Research, FDA 1401 Rockville Pike, Rockville, MD 20852, USA
2Division of Hematology, Office of Blood Research and Review, Center for Biologics Evaluation and Research, FDA 1401 Rockville Pike, Rockville, MD 20852, USA

Received 16 January 2014; Revised 11 February 2014; Accepted 26 February 2014; Published 27 March 2014

Academic Editor: Yoichi Hiasa

Copyright © 2014 Li Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Weinbaum, I. Williams, E. E. Mast et al., “Recommendations for identification and public health management of persons with chronic hepatitis B virus infection,” MMWR Recommendations and Reports, vol. 57, article RR08, pp. 1–20, 2008. View at Google Scholar · View at Scopus
  2. M. F. Sorrell, E. A. Belongia, J. Costa et al., “National Institutes of Health Consensus Development Conference Statement: management of hepatitis B,” Annals of Internal Medicine, vol. 150, no. 2, pp. 104–110, 2009. View at Google Scholar · View at Scopus
  3. C. W. Shepard, E. P. Simard, L. Finelli, A. E. Fiore, and B. P. Bell, “Hepatitis B virus infection: epidemiology and vaccination,” Epidemiologic Reviews, vol. 28, no. 1, pp. 112–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. WHO, “Hepatitis B vaccines,” The Weekly Epidemiological Record, vol. 84, no. 40, pp. 405–419, 2009. View at Google Scholar
  5. C. E. Stevens, R. P. Beasley, J. Tsui, and W. C. Lee, “Vertical transmission of hepatitis B antigen in Taiwan,” The New England Journal of Medicine, vol. 292, no. 15, pp. 771–774, 1975. View at Google Scholar · View at Scopus
  6. E. E. Mast, H. S. Margolis, A. E. Fiore et al., “A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents,” MMWR Recommendations and Reports, vol. 54, article RR16, pp. 1–31, 2005. View at Google Scholar · View at Scopus
  7. E. E. Mast, C. M. Weinbaum, A. E. Fiore et al., “A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults,” MMWR Recommendations and Reports, vol. 55, article RR16, pp. 1–25, 2006. View at Google Scholar · View at Scopus
  8. G. Borgia, M. A. Carleo, G. B. Gaeta, and I. Gentile, “Hepatitis B in pregnancy,” World Journal of Gastroenterology, vol. 18, no. 34, pp. 4677–4683, 2012. View at Publisher · View at Google Scholar
  9. H. M. H. Ip, V. C. W. Wong, P. N. Lelie, M. C. Kuhns, and H. W. Reesink, “Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA,” The Lancet, vol. 1, no. 8635, pp. 406–410, 1989. View at Google Scholar · View at Scopus
  10. Z. Shi, X. Li, L. Ma, and Y. Yang, “Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission—a meta-analysis,” International Journal of Infectious Diseases, vol. 14, no. 7, pp. e622–e634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Söderström, G. Norkrans, and M. Lindh, “Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission,” Scandinavian Journal of Infectious Diseases, vol. 35, no. 11-12, pp. 814–819, 2003. View at Google Scholar · View at Scopus
  12. N. Leung, “Chronic hepatitis B in Asian women of childbearing age,” Hepatology International, vol. 3, no. 1, pp. 24–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Elvidge, “Production of dated pregnant guinea pigs without post-partum matings,” Journal of the Institute of Animal Technicians, vol. 23, no. 3, pp. 111–117, 1972. View at Google Scholar
  14. E. B. Struble, L. Ma, L. Zhong, A. Lesher, J. Beren, and P. Zhang, “Human antibodies can cross guinea pig placenta and bind its neonatal Fc receptor: implications for studying immune prophylaxis and therapy during pregnancy,” Clinical and Developmental Immunology, vol. 2012, Article ID 538701, 9 pages, 2012. View at Publisher · View at Google Scholar
  15. J. W. Ward, “Time for renewed commitment to viral hepatitis prevention,” American Journal of Public Health, vol. 98, no. 5, pp. 779–781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. FitzSimons, G. Hendrickx, A. Vorsters, and D. P. Van, “Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011,” Vaccine, vol. 31, no. 4, pp. 584–590, 2013. View at Publisher · View at Google Scholar
  17. A. Zidan, H. Scheuerlein, S. Schule, U. Settmacher, and F. Rauchfuss, “Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in Iran and worldwide,” Hepatitis Monthly, vol. 12, no. 10, Article ID e6894, 2012. View at Publisher · View at Google Scholar
  18. N. Linder, T. H. Vishne, E. Levin et al., “Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols,” Infection, vol. 30, no. 3, pp. 136–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Hieber, D. Dalton, J. Shorey, and B. Combes, “Hepatitis and pregnancy,” Journal of Pediatrics, vol. 91, no. 4, pp. 545–549, 1977. View at Google Scholar · View at Scopus
  20. R. W. Pitcher-Wilmott, P. Hindocha, and C. B. S. Wood, “The placental transfer of IgG subclasses in human pregnancy,” Clinical and Experimental Immunology, vol. 41, no. 2, pp. 303–308, 1980. View at Google Scholar · View at Scopus
  21. A. Malek, R. Sager, and H. Schneider, “Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy,” American Journal of Reproductive Immunology, vol. 32, no. 1, pp. 8–14, 1994. View at Google Scholar · View at Scopus
  22. N. E. Simister, “Placental transport of immunoglobulin G,” Vaccine, vol. 21, no. 24, pp. 3365–3369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. W. A. Marasco and J. Sui, “The growth and potential of human antiviral monoclonal antibody therapeutics,” Nature Biotechnology, vol. 25, no. 12, pp. 1421–1434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Schupbach, H. Gunthard, M. S. C. Fung et al., “Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 disease,” Biotherapy, vol. 6, no. 3, pp. 205–215, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Onyango-Makumbi, S. B. Omer, M. Mubiru et al., “Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY),” Journal of Acquired Immune Deficiency Syndromes, vol. 58, no. 4, pp. 399–407, 2011. View at Publisher · View at Google Scholar · View at Scopus